Cash Flow ConcernsWith the Medicare Part B processing timeline sitting at approximately 150 days for ReWalk cases submitted this year, investors are likely to question whether the company’s present cash is sufficient to reach breakeven if these timelines do not accelerate.
Earnings MissThe company reported total revenues of $6.1M, which is lower than the consensus estimate of $8.4M, and a net loss of $0.35 per share, which is higher than the consensus estimated net loss of $0.32 per share.
Financial PerformanceQ3 results and 2024 revenue guidance both fell short of analyst expectations.